GenMont Biotech Incorporation announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 80.520 million compared to TWD 91.088 million a year ago. Operating income was TWD 19.346 million compared to TWD 25.563 million a year ago. Net income was TWD 8.917 million compared to TWD 41.161 million a year ago. Basic earnings per share was TWD 0.1 compared to TWD 0.46 a year ago.